Abstract
We examined the anxiolytic effects of a variety of anti-depressant drugs, administered either acutely or chronically, in an animal model of anxiety involving novelty-suppressed feeding in food-deprived rats. Following a single injection of desipramine (10 mg/kg), amitriptyline (10 mg/kg), mianserin (10 mg/kg), fluoxetine (10 mg/kg), buspirone (4 mg/kg), gepirone (4 mg/kg) or nomifensine (10 mg/kg), there was no decrease in the latency to begin eating in the novel environment such as occurred with diazepam (2 mg/kg). In fact, an increased latency was observed for desipramine, amitriptyline, fluoxetine, and nomifensine. In contrast, chronic (21 days) treatment with each of the above-mentioned drugs, except nomifensine, significantly reduced the latency to begin eating relative to vehicle controls. These findings suggest that a variety of tricyclic and novel anti-depressant drugs acquire anxiolytic properties following chronic administration.
This is a preview of subscription content, log in via an institution to check access.
References
Ballenger JC, Sheehan D, Jacobsen G (1977) Anti-depressant treatment of severe phobic anxiety. Paper read before the 130th Annual Meeting of the American Psychiatric Association, Toronto
Bodnoff SR, Suranyi-Cadotte B, Aitken DH, Quirion R, Meaney MJ (1988) The effects of chronic anti-depressant treatment in an animal model of anxiety. Psychopharmacology 95:298–302
Brogden RN, Heel RC, Speight TM, Avery GS (1979) Nomifensine: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 18:1–24
Charney DS, Redmond DE (1983) Neurobiological mechanisms in anxiety: evidence supporting central noradrenergic hyperactivity. Neuropharmacology 22:1531–1536
Charney DS, Heninger GR, Sternberg DE, Roth RH (1981a) Plasma MHPG in depression: effects of acute and chronic desipramine treatment. Psychiatr Res 5:217–229
Charney DS, Menkes DB, Heninger GR (1981b) Receptor sensitivity and the mechanism of action of anti-depressant treatment: implications for the etiology and therapy of depression. Arch Gen Psychiatry 38:1160–1180
Csanlosi I, Schweizer E, Case W, Rickels K (1987) Gepirone in anxiety: a pilot study. J Clin Pharmacol 27:31–193
Davis M, Redmond E, Baraban JM (1979) Noradrenergic agonists and antagonists: effects on conditioned fear as measured by the potentiated startle paradigm. Psychopharmacology 65:111–118
Glowinski J, Axelrod J (1964) Inhibition of uptake of tritiated noradrenaline in the intact rat brain by imipramine and structurally-related compounds. Nature 204:1318–1319
Goodlet I, Mireylees SE, Sugrue MF (1977) Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines. Br J Pharmacol 61:307–313
Hartmann RJ, Geller I (1971) p-Chlorophenylalanine effects on a conditioned emotional response in rats. Life Sci 10:927–933
Hollister LE (1978) Clinical pharmacology of psychotherapeutic drugs. Churchill Livingstone, New York
Hollister LE (1981) Second generation anti-depressant drugs. Psychosomatics 11:872–879
Iversen SD (1984) 5-HT and anxiety. Neuropharmacology 23:1553–1560
Kahn FJ, McNair D, Lipman RS, Covi L, Rickels K, Downing R, Fisher S, Frankenthaler LM (1986) Imipramine and chlordiazepoxide in depressive and anxiety disorder: efficacy in anxious outpatients. Arch Gen Psychiatry 43:79–85
Kahn RS, Praag HM van, Wetzler S, Asnis GM, Barr G (1988) Serotonin and anxiety revisited. Biol Psychiatry 23:189–208
Kelly D (1973) Progress in anxiety states. Proc R Soc Med 66:252–255
Kilts CD, Commissaris RL, Rech RH (1981) Comparison of anticonflict drug effects in three experimental models of anxiety. Psychopharmacology 74:290–296
Lavielle S, Tassin JP, Thierry HM, Blanc G, Herve D, Barthelemy C, Glowinski J (1978) Blockade by benzodiazepines of the selective high increase in dopamine turnover induced by stress in mesocortical dopaminergic neurons in rat. Brain Res 168:584–594
Marriott AS, Smith EF (1972) An analysis of drug effects in mice exposed to a simple novel environment. Psychopharmacologia 24:397–406
Mantigny C de, Aghajanian GK (1978) Tricyclic anti-depressants: long term treatment increases responsivity of rat forebrain neurons to serotonin. Science 202:1303–1306
Owens RT, Tyrer P (1983) Benzodiazepine dependence: a review of the evidence. Drugs 25:385–398
Poschel BPH (1971) A simple and specific screen for benzodiazepine-like drugs. Psychopharmacologia 19:193–198
Stein L, Wise CD, Berger BD (1973) Antianxiety actions of benzodiazepines: decrease in activity of serotonin neurons in the punishment system. In: Garattini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven Press, New York, pp 299–326
Type NC, Everitt BJ, Iversen SD (1977) 5-Hydroxytryptamine and punishment. Nature 268:741–742
Wong DT, Horng JS, Bymaster FP, Hauser KL, Molloy BB (1974) A selective inhibitor of serotonin uptake: Lilly 110140, 3-(P)-trifluoromethylphenoxy-N-methyl-3-phenypropylamine. Life Sci 15:471–479
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bodnoff, S.R., Suranyi-Cadotte, B., Quirion, R. et al. A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology 97, 277–279 (1989). https://doi.org/10.1007/BF00442264
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00442264